Russian Pharm company has obtained first compulsory patent licence under decision of Moscow commercial court. This patent licence provides the Russian company with right to produce and distribute in Russian market the medicament patented by USA pharm company. The Russian analogue of patented medicament is “much cheaper” in comparison with its original.
Comments closed